| | Family Health | Baby Health
Sex Selection: Methods, Ethics, Legal Status & Global Variation
Sex selection — choosing offspring sex — is ethically contentious and legally restricted in most jurisdictions.
Methods
Preconception
- Sperm sorting (MicroSort®): Flow cytometry separates X- vs Y-bearing sperm (DNA content diff ~2.8%). Enrichment: 90% X, 75% Y. Used with IUI/IVF. Not FDA-approved in US; available in some countries.
- Preimplantation Genetic Testing (PGT-A/PGT-M): IVF → embryo biopsy (trophectoderm, day 5/6) → sex chromosome analysis (XX/XY). Near 100% accuracy. Used for sex-linked disorders (hemophilia, Duchenne) or family balancing (where legal).
Postconception
- CVS (10–13 wks) / Amniocentesis (15–20 wks): Karyotype → sex determination. Selective termination for undesired sex. Highly restricted/prohibited in most countries.
- NIPT (cell-free DNA, 10+ wks): Fetal sex detection. Not diagnostic; confirmatory invasive test needed. Termination based on NIPT alone is ethically/legally fraught.
Legal & Ethical Landscape
| Country/Region | Policy |
|---|---|
| USA | No federal ban. ASRM: discourages non-medical sex selection. State laws vary. |
| UK (HFEA) | Prohibited for non-medical reasons. Allowed for serious sex-linked conditions. |
| Canada (AHRA) | Prohibited for non-medical sex selection. |
| Australia (NHMRC) | Prohibited for non-medical; allowed for genetic risk. |
| India (PCPNDT Act) | Strict ban on prenatal sex determination + selective abortion (female feticide crisis). |
| China | Ban on non-medical sex selection (relaxed 2021 for 3-child policy context). |
| Most EU | Prohibited for social sex selection (EU Tissue Directive). |
